WeVote
Log In

Bill

Bill

SB 493

Relating to short-acting opioid antagonists; declaring an emergency.

2025 Regular Session Introduced by Dacia Grayber and 1 co-sponsor

SB 493 addresses Oregon's access to short-acting opioid antagonists to combat overdose deaths, declaring the matter an emergency priority.

In committee upon adjournment.
0
WeVote Research Nonpartisan
Bill Summary · SB 493

Legislative bill overview

SB 493 addresses the availability and use of short-acting opioid antagonists (such as naloxone/Narcan) in Oregon, declaring the matter an emergency. The bill was introduced in January 2025 and has progressed through initial hearings and committee referral, though specific provisions are not detailed in the available action history.

Why is this important

Opioid antagonists are critical emergency medications that reverse opioid overdoses and save lives. Legislation in this area typically addresses barriers to access, distribution, training, or liability protections—all factors that directly impact overdose survival rates in communities experiencing the ongoing opioid crisis.

Potential points of contention

  • Access vs. cost: Balancing expanded availability of antagonists against pharmaceutical costs and who bears financial responsibility
  • Training and liability: Determining requirements for training users and establishing legal protections for bystanders or Good Samaritan provisions
  • Emergency declaration justification: Whether the "emergency" designation is warranted or represents legislative overreach to bypass normal procedures

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.